Cargando…

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke

OBJECTIVE: Intravenous thrombolytic therapy has become the standard of treatment for eligible patients with ischemic stroke. However, outcomes after receiving intravenous thrombolytic therapy vary widely. This study aims to investigate determinants of 1-year clinical outcomes of intravenous thrombol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Mingfeng, Yang, Jinwei, Cao, Xiaoyan, Li, Yingying, Xu, Hui, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357063/ https://www.ncbi.nlm.nih.gov/pubmed/37461226 http://dx.doi.org/10.1177/10760296231187616

Ejemplares similares

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Association Between the Change of Coagulation Parameters and Clinical Prognosis in Acute Ischemic Stroke Patients After Intravenous Thrombolysis With rt-PA
por: Wang, Yu, et al.
Publicado: (2021)

Clinical Significance and Dynamic Change of Coagulation Parameters in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)

Low MHR Is Associated with Hemorrhagic Transformation in Acute Large Artery Atherosclerosis Ischemic Stroke Patients with Intravenous Thrombolysis
por: Meng, Delong, et al.
Publicado: (2023)

Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA
por: Zhao, Jingru, et al.
Publicado: (2023)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Platelet-to-neutrophil Ratio after Intravenous Thrombolysis Predicts  Unfavorable Outcomes in Acute Ischemic Stroke
por: Wang, Mei-Qi, et al.
Publicado: (2020)

Factors Associated with Unfavorable Functional Outcomes After Intravenous Thrombolysis in Patients with Acute Ischemic Stroke
por: Satumanatpan, Nat, et al.
Publicado: (2022)

Proteinuria Independently Predicts Unfavorable Outcome of Ischemic Stroke Patients Receiving Intravenous Thrombolysis
por: Chen, Chih-Hao, et al.
Publicado: (2013)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis
por: Estella, A, et al.
Publicado: (2008)

Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Zhang, Xuting, et al.
Publicado: (2021)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2019)

Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke
por: Kim, Dae-Hyun, et al.
Publicado: (2018)

Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis
por: Huang, Baogang, et al.
Publicado: (2020)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2021)

Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Impact of Intravenous Alteplase Door-to-Needle Times on 2-Year Mortality in Patients With Acute Ischemic Stroke
por: Bhatt, Nirav R., et al.
Publicado: (2021)

Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience
por: Tsivgoulis, Georgios, et al.
Publicado: (2018)

Correction: Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy – Case Report and Review of Literature
por: Aleksic-Shihabi, Anka, et al.
Publicado: (2016)

Correlation Between Blood Glucose Variability and Early Therapeutic Effects After Intravenous Thrombolysis With Alteplase and Levels of Serum Inflammatory Factors in Patients With Acute Ischemic Stroke
por: Cai, Yun, et al.
Publicado: (2022)

Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan
por: Lin, Sheng‐Feng, et al.
Publicado: (2022)

Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012)

Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020)

Clinical significance of stroke nurse in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Xu, Zhao-Han, et al.
Publicado: (2021)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Stroke Code Improves Intravenous Thrombolysis Administration in Acute Ischemic Stroke
por: Chen, Chih-Hao, et al.
Publicado: (2014)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

High Level of the Fibrin Degradation Products at Admission Predicts Parenchymal Hematoma and Unfavorable Outcome of Ischemic Stroke After Intravenous Thrombolysis
por: Liu, Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrn6b6uj92pre4urntaqt0ltkd